RecruitingNCT06840288
Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry
Sponsor
M.D. Anderson Cancer Center
Enrollment
250 participants
Start Date
Feb 19, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients with peripheral lung tumors (primary or metastatic) that have been or will be ablated via robotic bronchoscopy.
Exclusion Criteria1
- Patients with planned bronchoscopic ablations of peripheral lung tumors that were aborted for technical reasons (ablation was not completed).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06840288